Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Novel Circulating Microvesicle-Based Multi-analyte Assay for the Detection of Prostate Cancer in Men With Elevated Risk for Prostate Cancer; the EMBRACE1 Study

NCT01499381 is registered in ClinicalTrials.gov with Caris Science, Inc. as lead sponsor.

NCT NCT01499381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01499381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Novel Circulating Microvesicle-Based Multi-analyte Assay for the Detection of Prostate Cancer in Men With Elevated Risk for Prostate Cancer; the EMBRACE1 Study
Lead sponsor
Caris Science, Inc.
Phase
Observational
Overall status
Completed
Start date
December 31, 2011
Completion date
July 31, 2012
Enrollment
1,290 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer